A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer.
A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer.
复制标题
DOI:
--
复制
发表时间:
1997-04
期刊:
影响因子:
11.2
通讯作者:
B. K. Sim;Michael S. O'Reilly;Hong Liang;A. Fortier;Weixuan He;John W. Madsen;Randall K. Lapcevich;Carol A. Nacy
中科院分区:
文献类型:
--
作者:
B. K. Sim;Michael S. O'Reilly;Hong Liang;A. Fortier;Weixuan He;John W. Madsen;Randall K. Lapcevich;Carol A. Nacy
Endogenous murine angiostatin, identified as an internal fragment of plasminogen, blocks neovascularization and growth of experimental primary and metastatic tumors in vivo. A recombinant protein comprising kringles 1-4 of human plasminogen (amino acids 93-470) expressed in Pichia pastoris had physical properties (molecular size, binding to lysine, reactivity with antibody to kringles 1-3) that mimicked native angiostatin. This recombinant Angiostatin protein inhibited the proliferation of bovine capillary endothelial cells in vitro. Systemic administration of recombinant Angiostatin protein at doses of 1.5 mg/kg suppressed the growth of Lewis lung carcinoma-low metastatic phenotype metastases in C57BL/6 mice by greater than 90%; administration of the recombinant protein at doses of 100 mg/kg also suppressed the growth of primary Lewis lung carcinoma-low metastatic phenotype tumors. These findings demonstrate unambiguously that the antiangiogenic and antitumor activity of endogenous angiostatin resides within kringles 1-4 of plasminogen.